Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of solar lentigines that occurred after adulthood~* age of 20 years or older.~Exclusion Criteria:~* uncontrolled systemic or chronic disease~* hypersensitivity to the ingredients of the ointment~* current use of skin whitening agents~* a history of other laser treatments within the past 6 months~* pregnancy~* lactation.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- epidermal growth factor (EGF) containing ointment group (Type: EXPERIMENTAL): The subjects received one session of laser treatment with a Q-swithced (QS) 532-nm Nd:yttrium aluminum garnet (YAG) laser after enrollment.~The procedure parameters were as follows: 5-10-ns pulse duration, 3.5-mm spot size, 0.9-1.1-J/cm2 fluence, and 2-Hz frequency.~The end point of laser treatment for lentigines was immediate whitening. The subjects then applied the epidermal growth factor (EGF) ointment twice daily (morning and evening) to the lesion for 4 weeks after laser treatment.
- Vehicle ointment group (Type: PLACEBO_COMPARATOR): The subjects received one session of laser treatment with a Q-swithced (QS) 532-nm Nd:yttrium aluminum garnet (YAG) laser of their solar lentigines after enrollment.~The procedure parameters were as follows: 5-10-ns pulse duration, 3.5-mm spot size, 0.9-1.1-J/cm2 fluence, and 2-Hz frequency.~The end point of laser treatment for lentigines was immediate whitening. The subjects then applied the vehicle ointment twice daily (morning and evening) to the lesion for 4 weeks after laser treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).